Back to Search Start Over

A new formula for estimation of low-density lipoprotein cholesterol in an ethnic Chinese population.

Authors :
Ching-Yun Hu
Chia-Lin Lee
H.-H. Sheu, Wayne
Jun-Sing Wang
I-Te Lee
Yuh-Min Song
Chia-Po Fu
Jiin-Tsae Ling
Yu-Fen Li
Shih-Yi Lin
Source :
Clinical Chemistry & Laboratory Medicine; Oct2015, Vol. 53 Issue 11, p1871-1879, 9p, 4 Charts, 4 Graphs
Publication Year :
2015

Abstract

Background: Low-density lipoprotein cholesterol (LDL-C) is an established risk factor for cardiovascular disease and is usually estimated by the Friedewald formula (FF) calculated from three parameters, namely, total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C). We aimed to develop a new and simple formula (NF) for LDL-C estimation. Methods: This cross-sectional study enrolled two study populations (a testing group, n = 16,749, and a validation group, n = 4940). Linear regression analysis was used in the testing group to investigate the association between measured LDL-C (mLDL-C) and TC concentration, and was verified in the validation group. Results: The NF yielded an estimated LDL-C (eLDL-C) equal to 0.75 x total cholesterol-0.6465 (mmol/L). For the subjects with TC between 2.58 and 7.74 mmol/L, the difference between mLDL-C and eLDL-C using the NF was less than that from the FF (testing group: -0.04 to -0.20 vs. -0.28 to -0.38 mmol/L; validation group: 0.01 to -0.12 vs. -0.23 to -0.30 mmol/L; p < 0.001, respectively). The predictability of the NF was not inferior to that of the FF in subjects with different triglyceride and HDL-C concentrations, and was not affected by diabetes diagnosis and statin use. However, the NF performed similar to or worse than the FF at TC concentrations < 2.58 mmol/L and > 7.74 mmol/L, respectively. Conclusions: In the Chinese population, the accuracy of eLDL-C measurement with the NF was better than that with the FF, especially in subjects with TC levels between 2.58 and 7.74 mmol/L. The NF is simple and may be used for screening as well as for follow-up of patients on lipid lowering agents. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14346621
Volume :
53
Issue :
11
Database :
Complementary Index
Journal :
Clinical Chemistry & Laboratory Medicine
Publication Type :
Academic Journal
Accession number :
110268544
Full Text :
https://doi.org/10.1515/cclm-2014-1029